Copyright
©The Author(s) 2004.
World J Gastroenterol. Nov 1, 2004; 10(21): 3165-3170
Published online Nov 1, 2004. doi: 10.3748/wjg.v10.i21.3165
Published online Nov 1, 2004. doi: 10.3748/wjg.v10.i21.3165
Figure 1 Intestinal lesions induced by meloxicam.
A: Normal control rats; B: AA rats; C: AA rats given meloxicam intragastrically; D: AA rats treated with oral CII; E: AA rats treated with nasal CII; F: AA + meloxicam rats treated with oral CII; and G: AA + meloxicam rats treated with nasal CII.
Figure 2 Effects of oral or nasal administration of CII on knee joint histopathology in AA rats with or without intragastrical administration of meloxicam (HE stain, × 100).
A: Normal control rats (grade 0); B: AA rats (grade 4); C: AA rats given meloxicam intragastrically (grade 4); D: AA rats treated with oral CII (grade 3); E: AA rats treated with nasal CII (grade 2); F: AA + meloxicam rats treated with oral CII (grade 3); and G: AA + meloxicam rats treated with nasal CII (grade 2).
- Citation: Zheng YQ, Wei W, Shen YX, Dai M, Liu LH. Oral and nasal administration of chicken type II collagen suppresses adjuvant arthritis in rats with intestinal lesions induced by meloxicam. World J Gastroenterol 2004; 10(21): 3165-3170
- URL: https://www.wjgnet.com/1007-9327/full/v10/i21/3165.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i21.3165